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Background
Although higher visit-to-visit variability (VVV) of blood pressure (BP) is 
associated with increased cardiovascular disease risk, the physiological 
basis for VVV of BP is incompletely understood.
Methods
We examined the associations of aortic distensibility (assessed by 
magnetic resonance imaging) and artery elasticity indices (deter-
mined by radial artery pulse contour analysis) with VVV of BP in 2,640 
and 4,560 participants, respectively, from the Multi-Ethnic Study of 
Atherosclerosis. Arterial measures were obtained at exam 1.  BP read-
ings were taken at exam 1 and at 3 follow-up visits at 18-month intervals 
(exams 2, 3, and 4). VVV was defined as the SD about each participant’s 
mean systolic BP (SBP) across visits.
results
The mean SDs of SBP were inversely associated with aortic dis-
tensibility: 7.7, 9.9, 10.9, and 13.2 mm Hg for quartiles 4, 3, 2, and 1 
of aortic distensibility, respectively (P trend < 0.001). This asso-
ciation remained significant after adjustment for demograph-
ics, cardiovascular risk factors, mean SBP, and antihypertensive 
medication use (P trend < 0.01). In a fully adjusted model, lower 
quartiles of large artery and small artery elasticity (LAE and 
SAE) indices were also associated with higher mean SD of SBP 
(P trend = 0.02 for LAE; P trend < 0.001 for SAE).
conclusions
In this multiethnic cohort, functional alterations of central and 
peripheral arteries were associated with greater long-term VVV of SBP.
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There is increasing evidence to suggest that visit-to-visit 
variability (VVV) of blood pressure (BP) has prognostic 
value, independent of average BP. Increased VVV of BP is 
associated with a higher risk of cardiovascular events1–4 and 
all-cause mortality.5,6
Presently, the mechanisms underlying higher levels of 
VVV in BP are unknown. Because increased pulse pressure 
is associated with higher levels of VVV of BP, it has been 
hypothesized that alterations in the elastic properties of the 
arterial tree may contribute to higher levels of VVV of BP.1,6,7 
However, few data are available on the association between 
functional vascular alterations and VVV of BP.
Because of its elastic properties and proximity to vital 
organs such as the heart, brain, and kidneys, the aorta 
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modulates the entire vascular tree, buffering the pulsatile 
cardiac output to provide constant flow to the microvas-
cular system including capillary beds. Therefore, reduced 
aortic distensibility may be associated with a higher level 
of VVV of BP. Although decreased aortic distensibility is 
associated with microvascular dysfunction,8 it is unclear 
whether reduced small arterial elasticity (SAE) is also asso-
ciated with a higher level of VVV of BP. We, therefore, evalu-
ated whether aortic distensibility and large arterial elasticity 
(LAE) and SAE are associated with VVV of BP in a multi-




This analysis included participants from the Multi-
Ethnic Study of Atherosclerosis (MESA), a population-
based study of 6,814 community-dwelling adults aged 
45–84  years and free of clinically evident cardiovascular 
disease at baseline. Details of the MESA study design 
are described elsewhere.9 Participants from 4 ethnic 
groups (white, black, Hispanic, and Asian primarily of 
Chinese descent) were recruited from 6 US communities 
(Baltimore, Maryland; Chicago, Illinois; Forsyth County, 
North Carolina; Los Angeles County, California; north-
ern Manhattan, New York; and St. Paul, Minnesota). The 
study was approved by the institutional review boards of 
all participating sites, and written informed consent was 
obtained from all participants.
Clinical and biochemical measures were obtained at 
exam 1 and subsequent MESA exams (exams 2–4), which 
were conducted at 18-month intervals. Detailed informa-
tion about the measures is provided at the MESA website 
(http://mesa-nhlbi.org/moreinfo.aspx). The Supplementary 
Methods provides details on how the cardiovascular risk 
factors at exam 1, which were used in our analyses, were 
ascertained and defined.
MESA participants underwent a cardiac magnetic res-
onance imaging (MRI) scan at exam 1.10 Thoracic aortic 
distensibility determined by MRI was measured in a sub-
set that included 3,541 participants. In addition, 6,336 
participants successfully underwent measurement of LAE 
and SAE indices determined by radial artery pulse wave 
analysis at exam 1.  BP data from exams 1–4 were used 
for the estimation of VVV of BP (see below). For these 
analyses of aortic distensibility, participants who did not 
have BP data available from all 4 exams (n = 584) or were 
missing covariable data (n = 317) were excluded. Similarly, 
for analyses of artery elasticity, participants who did not 
have BP data available from all 4 exams (n  =  1,232) or 
were missing covariable data (n  =  544) were excluded. 
After these exclusions, 2,640 participants were included in 
the analyses of aortic distensibility and VVV of BP, and 
4,560 participants were included in the analyses of arterial 
elasticity and VVV of BP. The distribution of age, sex, and 
body mass index for MESA participants included and not 
included in these analyses are presented in Supplementary 
Table S1.
thoracic aortic distensibility assessed by Mri (exam 1)
Aortic distensibility was assessed using 1.5-T whole-body 
MRI systems, Signa CV/I, or Signa LX (General Electric 
Medical Systems, Wisconsin), as previously described.11,12 
MRI scans of the thoracic aorta were obtained using gradi-
ent-echocardiographic phase-contrast cine MRI with elec-
trocardiographic gating. Images of the aorta were obtained 
in the transverse plane at the level of the right pulmonary 
artery perpendicular to the vessel lumen.
Distensibility of the ascending aorta was calculated using 
the following formula: (maximum cross-sectional area − 
minimum cross-sectional area)/(minimum cross-sectional 
area × pulse pressure). Noninvasive brachial BP was measured 
immediately before and after the MRI aortic measurements 
while the patient was in the supine position in the MRI scanner 
using a nonferromagnetic arm blood pressure cuff; the aver-
age systolic and diastolic values were used to calculate pulse 
pressure, which was defined as SBP minus diastolic BP. The 
maximum and minimum areas of the ascending aorta were 
determined using an automated contour routine using the 
software FLOW (Medis Medical Imaging Systems, Raleigh, 
NC). Aortic distensibility determined by MRI is highly repro-
ducible with coefficient of variation for intraobserver and 
interobserver variability of 1% and 2%, respectively.13
lae and sae indices (exam 1)
LAE and SAE indices (in ml/mm Hg) were assessed using 
the PulseWave CR-2000 Research CardioVascular Profiling 
Instrument (Hypertension Diagnostics, Eagan, MN), which 
analyzes radial artery pulse waveforms. This methodology 
has been validated for the assessment of arterial elastic-
ity14–19 and is highly reproducible.14,20,21 While the partici-
pant was supine, the pulse pressure sensor was positioned 
on the right wrist, supported by a wrist stabilizer, and meas-
urements were taken for 30 seconds. An automated, oscil-
latory BP measurement was performed at the contralateral 
arm. A computer-based, third-order, 4-element Windkessel 
model was used to calculate an elasticity index for both large 
(C1) and small (C2) arteries by analyzing the diastolic pulse 
contour. The values estimated directly from the waveform 
were X and Y for LAE and SAE, respectively. LAE and SAE 
indices were then estimated by dividing each of X and Y by 
systemic vascular resistance. Systemic vascular resistance 
was calculated by dividing the mean arterial pressure by the 
cardiac output. Cardiac output was estimated from the ejec-
tion time determined from the pulse waveform, heart rate, 
age, height, and weight. The correlations for repeat measure-
ments are 0.74 for LAE index and 0.84 for SAE index.22
BP measurements and antihypertensive medication use 
(exams 1–4)
At each exam, BP was measured 3 times at 2-minute 
intervals using an automated oscillometric device (Dinamap 
Monitor Pro 100, GE Healthcare, Milwaukee, WI) after par-
ticipants had rested for 5 minutes in the seated position. 
Appropriate-sized cuffs were used for BP assessment. BP at 
each exam was defined as the average of the second and third 
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readings. Participants were also asked to bring their medica-
tions to each exam, and antihypertensive drug use was deter-
mined using a medication inventory. The following classes 
were considered to be antihypertensive medications: diuret-
ics, beta-blockers, angiotensin-converting enzyme inhibitors, 
angiotensin receptor blockers, calcium channel blockers, and 
alpha-blockers or other peripheral vasodilators.
statistical analyses
The primary outcome of VVV of BP was defined as the SD 
about the participant’s mean SBP1,6 across exams 1–4. Because 
aortic distensibility, LAE, and SAE had skewed distributions, 
the study population was divided into quartiles based on 
the distribution of each measure. Sample characteristics and 
the mean level of SD of SBP were calculated by quartile of 
aortic distensibility. Unadjusted differences in mean SD of 
SBP by quartile of aortic distensibility were estimated using 
a linear regression model with the highest quartile (quartile 
4)  serving as the referent group. Additional models with 
multivariable adjustment for covariables that might be 
related to aortic distensibility and SD of SBP were also fitted. 
In addition to demographics (age, sex, and ethnicity) and 
MESA site, which were included in model 1, the following 
exam 1 covariables (all chosen a priori) were included in 
model 2: body mass index, diabetes, low-density lipoprotein 
and high-density lipoprotein cholesterol levels, cigarette 
smoking, education level (high school or above), physical 
activity, reduced estimated glomerular filtration rate, and 
C-reactive protein. Physical activity and C-reactive protein 
levels were natural log transformed because of skewed 
distributions. Subsequent models included additional 
adjustment for mean SBP across exams 1–4 (model 3) and 
antihypertensive medication use across exams 1–4 (model 4). 
Antihypertensive medication use across visits was modeled 
as never (not on antihypertensive medications at any exams), 
always (on antihypertensive medications at all exams), and 
sometimes (on antihypertensive medications at some but 
not all exams). Linear trends across quartiles were assessed 
by including the quartile-specific median aortic distensibility 
values as a continuous variable in the regression models. 
These analyses were repeated for the LAE and SAE indices.
Several sensitivity analyses were performed. First, preva-
lence ratios for the outcome of being in the highest quartile 
of SD of SBP (≥13.48 mm Hg), associated with quartiles of 
aortic distensibility, LAE, and SAE, were calculated using 
log-binomial regression models with quartile 4 of each arte-
rial measure serving as the referent group. Second, the asso-
ciations of quartiles of aortic distensibility and LAE and SAE 
indices with other VVV measures, including coefficient of 
variation and variation independent of the mean,1,6 were 
assessed. Third, the associations between aortic distensibil-
ity, LAE, and SAE, expressed as continuous variables, and 
SD of SBP as a continuous variable were evaluated. Because 
of skewed distributions, aortic distensibility, LAE, and SAE 
were natural log transformed.
Pulse pressure and mean arterial pressure are both par-
tially determined by mean SBP. Because pulse pressure is 
used to derive aortic distensibility, and age, height, weight, 
and mean arterial pressure are used to derive LAE and SAE 
indices, variance inflation factors were calculated to exam-
ine the possible existence of multicollinearity between aortic 
distensibility and mean SBP and multicollinearity among 
both arterial elasticity indices (LAE and SAE), age, body 
mass index, and mean SBP. The variance inflation factors 
were all <2.3, indicating multicollinearity was not present 
among the predictors.23
Statistical significance was defined by α = 0.05 level, 2-tailed. 
Statistical analyses were conducted with SAS version 9.2 
(SAS Institute, Cary, NC) and SPSS 18.0 (SPSS, Chicago, IL).
results
Table  1 shows the characteristics of the sample accord-
ing to aortic distensibility quartiles. Older age, female sex, 
black ethnicity, lower education level, diabetes, higher high-
density lipoprotein levels, higher C-reactive protein levels, 
reduced estimated glomerular filtration rate, lower physical 
activity, antihypertensive medication use, and higher mean 
SBP and diastolic BP levels were associated with lower aor-
tic distensibility quartiles. Chinese ethnicity was associated 
with higher aortic distensibility. Supplementary Tables S2 
and S3 show the characteristics of the sample according to 
quartiles of LAE and SAE indices, respectively.
association between aortic distensibility and VVV of BP
For the aortic distensibility analysis (n = 2,640), the mean 
of the SD of SBP was 10.4 mm Hg (SD = 6.5). Figure 1 (upper 
panel) shows mean and 95% confidence interval (CI) for 
SD of SBP by quartile of aortic distensibility (quartile 4: 
7.7 mm Hg; quartile 3: 9.9 mm Hg; quartile 2: 10.9 mm Hg; 
and quartile 1: 13.2 mm Hg). Compared with participants in 
the highest quartile (quartile 4), those in the lower quartiles 
of aortic distensibility had higher mean SD of SBP (Table 2). 
After adjustment for age, sex, ethnicity, and MESA site 
(model 1, Table 2) and additional adjustment for body mass 
index, diabetes, low-density lipoprotein and high-density 
lipoprotein cholesterol levels, cigarette smoking, education 
level, physical activity, reduced estimated glomerular 
filtration rate, and C-reactive protein (model 2, Table  2), 
these associations remained statistically significant (P trend 
< 0.001 for both models 1 and 2). After further adjustment 
for mean SBP across exams 1–4 (model 3, Table  2) and 
antihypertensive medication use across exams 1–4 (model 4, 
Table 2), the association between aortic distensibility and SD 
of SBP was attenuated but remained statistically significant.
associations between lae and sae indices and VVV of BP
For the artery elasticity indices analyses (n = 4,560), the 
mean of the SD of SBP was 10.8 mm Hg (SD = 6.6). The mid-
dle and bottom panels of Figure 1 show mean and 95% CI 
for SD of SBP by quartile of LAE and SAE index, respec-
tively (quartile 4: 8.8 mm Hg; quartile 3: 9.7 mm Hg; quartile 
2: 11.0 mm Hg; and quartile 1: 13.6 mm Hg for LAE index; 
quartile 4: 8.2 mm Hg; quartile 3: 10.0 mm Hg; quartile 2: 
11.7 mm Hg; and quartile 1: 13.1 mm Hg for SAE index). 
These associations remained statistically significant after 
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multivariable adjustment (see models 1–4 in Supplementary 
Tables S4 and S5).
sensitivity analyses
The prevalence of SD of SBP ≥ 13.48 mm Hg, the high-
est quartile of SD of SBP, was 10.9% for quartile 4, 22.6% 
for quartile 3, 27.1% for quartile 2, and 39.4% for quartile 1 
of aortic distensibility (Supplementary Table S6). In a fully 
adjusted model (model 4, Supplementary Table S6), the 
prevalence ratios of SD of SBP ≥ 13.48 mm Hg associated 
with quartiles 3, 2, and 1 versus quartile 4 of aortic distensi-
bility were 1.48 (95% CI = 1.16–1.89), 1.40 (95% CI = 1.09–
1.78), and 1.58 (95% CI  =  1.24–2.03), respectively. The 
prevalence of SD of SBP ≥ 13.48 mm Hg was 17.2%, 20.4%, 
26.6%, and 42.3% for quartiles 4, 3, 2, and 1 of LAE index, 
respectively (Supplementary Table S7), and 12.8%, 22.6%, 
31.6%, and 39.5% for quartiles 4, 3, 2, and 1 of SAE index, 
respectively (Supplementary Table S8). In a fully adjusted 
model (model 4, Supplementary Table S7) and compared 
with quartile 4 of LAE index, the prevalence ratios of SD 
of SBP ≥ 13.48 mm Hg were 1.03 (95% CI  =  0.88–1.21), 
1.10 (95% CI = 0.94–1.28), and 1.19 (95% CI = 1.02–1.40) 
for quartiles 3, 2, and 1, respectively (P trend = 0.03). In a 
fully adjusted model (model 4, Supplementary Table S8) 
and compared with quartile 4 of SAE index, the prevalence 
ratios (95% CI) were 1.28 (95% CI = 1.07–1.52), 1.44 (95% 
CI = 1.20–1.71), and 1.56 (95% CI = 1.30–1.87) for quartiles 
3, 2 and 1, respectively (P trend < 0.001). When VVV was 
defined as coefficient of variation and separately as varia-
tion independent of the mean, the findings were similar in 
a fully adjusted model to the results obtained using SD of 
SBP (model 4, Supplementary Tables S9 and S10). In a fully 
adjusted model, lower aortic distensibility, LAE, and SAE, 
Table 1. Characteristics of Multi-Ethnic Study of Artherosclerosis participants included in the analysis of thoracic aortic distensibility and SD 
of systolic blood pressure 
Characteristics
Quartiles of aortic distensibility
Q4 (n = 660) Q3 (n = 660) Q2 (n = 660) Q1 (n = 660) P trend
Aortic distensibility, 10−3/mm Hg >2.34 1.59–2.34 1.07–1.58 <1.07 —
Mean age (SD), years 53.7 (7.7) 58.2 (8.7) 62.9 (9.1) 66.2 (8.7) <0.001
Female, % 52.7% 50.2% 55.9% 58.8% <0.01
Race/ethnicity
  White (referent), % 43.2% 44.1% 43.6% 41.4% —
 Chinese American, % 16.2% 11.8% 10.9% 9.1% <0.01
 Black, % 22.1% 27.1% 31.8% 34.2% <0.001
 Hispanic, % 18.5% 17.0% 13.6% 15.3% 0.19
High school education or above, % 90.5% 87.9% 87.3% 84.1% <0.01
Current smoker, % 11.4% 12.9% 12.4% 10.3% 0.52
Diabetes, % 5.6% 7.6% 10.0% 12.4% <0.001
Mean BMI (SD), kg/m2 27.7 (4.9) 28.1 (5.2) 27.5 (4.9) 27.8 (4.8) 0.69
Mean LDL-cholesterol (SD), mg/dl 118.8 (31.2) 117.5 (30.4) 116.7 (30.5) 116.7 (31.0) 0.18
Mean HDL-cholesterol (SD), mg/dl 51.0 (14.7) 51.3 (15.8) 53.0 (15.7) 52.9 (14.3) <0.01
Median CRP (25-75th percentile), mg/L 1.6 (0.7–3.8) 1.8 (0.8–3.8) 1.8 (0.8–4.0) 2.1 (0.8–4.4) <0.01
Mean eGFR (SD), mg/dl 83.9 (15.7) 83.1 (16.8) 79.8 (15.9) 78.8 (18.2) <0.001
Reduced eGFRa 3.5% 6.1% 9.4% 13.5% <0.001
Median physical activity level (25th–75th 
percentile), 1000 METs-min/wk
4.6 (2.4–7.9) 4.6 (2.3–8.0) 4.2 (2.3–8.4) 3.9 (2.0–7.1) <0.01
Antihypertensive medicationsb
 Never taking across exams (referent), % 70.0% 55.0% 43.2% 29.4% —
 Taking across all exams, % 15.3% 23.8% 32.9% 44.2% <0.001
 Sometimes taking, % 14.7% 21.2% 23.9% 26.4% <0.001
Mean SBP (SD), mm Hg 112.9 (13.8) 120.2 (14.9) 125.2 (17.0) 131.0 (16.9) <0.001
Mean DBP (SD), mm Hg 69.2 (8.4) 71.0 (8.6) 70.3 (8.6) 71.2 (8.8) 0.001
Abbreviations: BMI, body mass index; CRP, C-reactive protein; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; 
HDL, high-density lipoprotein; LDL, low-density lipoprotein; METs = metabolic equivalent values; SBP, systolic blood pressure.
aeGFR < 60 ml/min/1.73 m2.
bParticipants were classified as: never taking across exams (on no antihypertensive medications at all exams), taking across all exams (on 
antihypertensive medications at all exams), and sometimes taking across exams.
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expressed as continuous variables, were significantly associ-
ated with higher SD of SBP (model 4, Supplementary Table 
S11). The associations between quartiles of aortic distensi-
bility, LAE, and SAE and SD of SBP were similar when the 
slope of SBP across exams 1–4 was added to model 4 and 
also when SD of SBP was derived from SBP obtained from 
exams 2–4 rather than from exams 1–4 in model 4 (results 
not shown).
discussion
We found that lower aortic distensibility by MRI and 
lower LAE and SAE indices by pulse contour analysis were 
associated with higher levels of SD of SBP. These findings 
suggest that alterations in arterial function may contribute 
to greater VVV of SBP.
Scarce data are available on the association between arte-
rial vascular function and VVV of BP.7 In an outpatient 
cohort of 201 elderly Japanese patients with ≥ 1 cardiovas-
cular disease risk factors, Nagai et al.7 found an association 
between common carotid artery stiffness and VVV of BP, 
independent of age, smoking, and high-density lipoprotein 
level. Our results extend these findings by demonstrating 
that reduced aortic distensibility and arterial elasticity were 
both associated with a higher level of VVV of BP in a large, 
multiethnic, population-based cohort. This association was 
present after adjustment for several important confounders 
such as age, sex, race/ethnicity, cardiovascular risk factors, 
mean SBP, and antihypertensive medication use.
In our study, functional alterations in the aorta and other 
large vessels were associated with higher levels of VVV of 
BP. Although the mechanisms underlying this relation 
are unknown, some evidence suggests that baroreceptor 
insensitivity may underlie the link between large artery 
vascular changes and VVV of BP.24,25 Increases in beat-
to-beat BP variability are associated with a reduction in 
baroreceptor sensitivity,24 and prior evidence suggests that 
large artery stiffness is a major determinant of reduced 
baroreceptor sensitivity.25 Further, a recent report26 indicated 
that BP variability over a 24-hour period was associated with 
large artery stiffness in hypertensive patients. Whether this 
mechanistic pathway can be extended to the associations of 
aortic distensibility and LAE with VVV of BP is unclear.
In addition, our findings also suggest an association 
between small artery alterations and VVV of BP. Changes 
in SAE may be due to mechanisms that are closely linked to 
nitric oxide–mediated endothelial dysfunction.27 In a sam-
ple of 36 black subjects, Diaz et  al.28 showed that VVV of 
BP is higher in blacks with decreased endothelial function. 
Therefore, reduced SAE and endothelial dysfunction may be 
overlapping biological domains that underlie VVV of BP.
Finally, we studied long-term VVV as BP readings were 
taken at 18-month intervals. The optimal period between 
visits for the estimation of VVV is unknown. In the studies 
that have demonstrated associations between VVV and car-
diovascular disease events or subclinical disease, the inter-
vals between visits have ranged from several days6 to several 
years.3,29 Whether our results can be extended to VVV esti-
mated from shorter or longer intervals remains unknown.
There are several potential limitations to our study. Pulse 
wave velocity, considered by some investigators to be the 
gold standard methodology to assess arterial stiffness,30 was 
not measured in MESA. However, MRI for the assessment of 
distensibility has been shown to have better quality of vali-
dation and less operator bias compared with other methods 
of aortic stiffness assessment.31 Another possible limitation 
is that peripheral BP rather than central BP was used to 
calculate aortic distensibility. Further, although some stud-
ies have questioned the assumptions about the arterial tree 
Figure 1. SD of systolic blood pressure (SBP) across exams 1–4 by quar-
tile of aortic distensibility (top panel), large artery distensibility (LAE) 
index (middle panel), and small artery distensibility (SAE) index (bottom 
panel). Data are expressed as mean (bar) with 95% confidence intervals 
(line). For aortic distenstibility, LAE, and SAE, P trends are all < 0.001.
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when using the modified Windkessel model of circulation,31 
the method of arterial elasticity used in our study has a high 
degree of correlation with the same measurements obtained 
invasively19 and is associated with important clinical out-
comes. In MESA, estimates of LAE and SAE are associated 
with incident hypertension, cardiovascular outcomes, and 
kidney function decline.14,17,32 In addition, despite our use of 
different noninvasive techniques to measure the functional 
properties of large and small arteries, the findings were simi-
lar, providing stronger evidence in support of our hypoth-
eses linking these changes with VVV of BP. Whether similar 
associations exist between VVV of BP and pulse wave veloc-
ity or other vascular measures such as 24-hour ambulatory 
arterial stiffness index,33 is unknown. Further, this study 
cannot ascertain whether functional arterial alterations pre-
cede or are a result of higher levels of VVV of BP. However, 
the results were similar when VVV of BP was derived from 
BP obtained from exams 2–4, suggesting that alterations in 
the arterial tree preceded VVV of BP in our study. Finally, 
because we only had 4 visits to assess VVV of BP, it is possi-
ble that measurement error was present. However, the pres-
ence of measurement error would have biased our results 
toward the null: the association between VVV of BP and the 
vascular measures would have been even stronger if meas-
urement error was eliminated.
Major strengths of this study include the large sample size, 
the inclusion of a multiethnic, population-based sample that 
was drawn from several communities in the United States, 
and the careful and standardized assessment of vascular 
measures and cardiovascular risk factors including BP read-
ings across time. Further, this is one of the first studies to 
examine the independent associations of aortic distensibil-
ity, LAE, and SAE with VVV of BP.
In summary, we found that aortic distensibility, LAE, and 
SAE were associated with higher long-term VVV of SBP in 
a large, multiethnic, population-based study. These findings 
are consistent with the hypothesis that functional alterations 
in central and peripheral arteries contribute to the long-term 
variability in SBP obtained over time in the clinic setting. 
Future studies should confirm these findings by examin-
ing the longitudinal associations of aortic distensibility and 
artery elasticity indices with VVV of BP. Also the biological 
mechanisms underlying the association between these arte-
rial parameters and greater VVV of BP should be examined.
suPPleMentarY Material
Supplementary materials are available at American Journal 
of Hypertension (http://ajh.oxfordjournals.org).
acknoWledgMents
The authors thank the other investigators, the staff, and 
the participants of the MESA study for their valuable con-
tributions. A  full list of participating MESA investigators 
and institutions can be found at http://www.mesa-nhlbi.org. 
MESA was supported by contracts N01-HC-95159 through 
N01-HC-95166, N01-HC-95167, and R01-HL077612 from 
the National Heart, Lung, and Blood Institute; and UL1 
RR024156 from the National Center for Research Resources 
and the National Center for Advancing Translational 
Sciences, National Institutes of Health. Dr Newman is sup-
ported by 5T32HL007854-16 from the National Heart, Lung, 
and Blood Institute.
disclosure
The authors declared no conflict of interest.
Table 2. Unadjusted and adjusted differences in mean SD of systolic blood pressure by quartiles of thoracic aortic distensibility 
Characteristics and Models
Quartiles of aortic distensibility
Q4 (referent) 
(n = 660) Q3 (n = 660) Q2 (n = 660) Q1 (n = 660) P trenda
Aortic distensibility, 
10−3/mm Hg
>2.34 1.59–2.34 1.07–1.58 <1.07 —
Unadjusted 0 (referent) 2.24 (0.34) 3.16 (0.34) 5.54 (0.34) <0.001
Model 1b 0 (referent) 1.58 (0.34) 1.82 (0.36) 3.61 (0.38) <0.001
Model 2c 0 (referent) 1.48 (0.33) 1.77 (0.35) 3.42 (0.37) <0.001
Model 3d 0 (referent) 0.80 (0.32) 0.63 (0.34) 1.76 (0.36) <0.001
Model 4e 0 (referent) 0.69 (0.31) 0.41 (0.33) 1.42 (0.36) <0.01
Numbers in table are difference in mean (SE) SD of SBP compared with quartile 4 of thoracic aortic distensibility.
aP value represents the linear trend across quartiles (with each quartile represented by the median value within the quartile).
bModel 1 includes adjustment for age, sex, race/ethnicity, and Multi-Ethnic Study of Artherosclerosis site.
cModel 2 includes adjustment for variables in model 1 and body mass index, diabetes, low-density lipoprotein and high-density lipoprotein 
cholesterol levels, cigarette smoking, education level (high school or above), physical activity, reduced estimated glomerular filtration rate, and 
C-reactive protein.
dModel 3 includes adjustment for variables in model 2 and mean systolic blood pressure levels (across exams 1–4).
eModel 4 includes adjustment for variables in model 3 and use of antihypertensive medication (never taking across exams, taking across all 
exams, sometimes taking across exams).
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